Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1245 of 6351
-
New cell therapy aims to boost hearing restoration in cochlear implant patients
Disease control Not yet recruitingRinri Therapeutics is conducting a clinical trial of a new cell therapy called Rincell-1. Rincell-1 is being developed to treat adults with neural hearing loss, either age related hearing loss or auditory neuropathy, who also meet criteria for a cochlear implant. The goals of thi…
Phase 1/2 • Sponsor: Rinri Therapeutics • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
AI listens for dementia: new speech test could speed up diagnosis
Diagnosis Not yet recruitingThe goal of this observational study is to learn if an artificial intelligence (AI)-based speech analysis tool can identify which patients with memory problems need specialist evaluation at a memory clinic. The main questions it aims to answer are: Can the AI model accurately di…
Sponsor: Zealand University Hospital • Aim: Diagnosis
Last updated Sep 04, 2026 00:00 UTC
-
Radioactive drug aims to supercharge cancer immunotherapy
Disease control Recruiting nowParticipants with metastatic cancer who are taking anti-PD-1 or anti-PD-L1 therapy will be enrolled to assess the safety of and find the optimal dose for radioactive imaging agents and to explore whether these agents will make current drug therapies work better. Up to 60 particip…
Phase 1 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can a withdrawn myeloma drug make a comeback with a gentler schedule?
Disease control Not yet recruitingThis is a research study to find out if a drug called belantamab mafodotin in combination with dexamethasone, a steroid, can be safely and effectively given in the community setting. Belantamab mafodotin (BLENREP) was approved in the US in August 2020 under an FDA program called …
Phase 2 • Sponsor: Cristiana Costa Chase, DO • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New combo therapy aims to shrink enlarged spleens in bone marrow cancer patients
Disease control Not yet recruitingThis is an open-label, single-arm, Phase 2 interventional study designed to evaluate the safety and efficacy of Bomedemstat (IMG-7289) when added to Momelotinib in patients with Myelofibrosis (MF) who exhibit a suboptimal response to Momelotinib alone or who present with baseline…
Phase 2 • Sponsor: United Lincolnshire Hospitals NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Weight-Loss drug may curb alcohol cravings in fatty liver patients
Disease control Not yet recruitingThere is evidence that alcoholic beverage consumption significantly interacts with food energy intake. Furthermore, there is accumulating evidence showing independent, combined, and modifying effects of alcohol and metabolic factors on the onset and progression of chronic liver d…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New trial aims to stop CMV eye inflammation from returning
Disease control Not yet recruitingThe goal of this clinical trial is to compare antiviral treatment strategies for cytomegalovirus (CMV) anterior uveitis - a viral infection causing inflammation inside the front of the eye - in immunocompetent adults aged 18 years and older. The main questions it aims to answer a…
Phase 2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Smart wristbands may spot malaria before symptoms strike
Diagnosis Not yet recruitingIn order to control infections, the investigators must first detect them. Biosensor devices may allow early detection and intervention for infectious diseases, helping the investigators to recognize infections early, and allow for early treatment. This will lower transmission of …
Phase 1 • Sponsor: University of Maryland, Baltimore • Aim: Diagnosis
Last updated Sep 10, 2026 03:00 UTC
-
New trial aims to match diabetes drugs to patients for better heart and kidney protection
Disease control Not yet recruitingBreakthrough T1D has awarded support for a joint University of Michigan-Oregon Health \& Science University Center of Excellence (CoE) to address cardio-renal complications in T1D. The overarching hypothesis of the CoE is that individuals with T1D have unique endophenotypes deter…
Phase 2 • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
App aims to cut Post-Surgery complications in digestive cancer patients
Symptom relief CancelledIn France, digestive cancers are responsible for more than 40,000 deaths per year, or approximately 30% of cancer-related deaths. Surgery is central to the patient's journey, particularly their treatment, and postoperative complications, whether cardiovascular, respiratory, infe…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Eye drops could replace needle injections for wet AMD
Disease control Not yet recruitingTrial to Evaluate the Safety and Efficacy of SCAI-005 Ophthalmic solution in Patients with Neovascular Age-related Macular Degeneration. The purpose of this study is to investigate the efficacy, safety and tolerability of SCAI-005 Ophthalmic solution by dose in patients with neo…
Phase 2 • Sponsor: SCAI Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Smartwatch could alert doctors to brain cancer complications before they worsen
Disease control Not yet recruitingThis research study is for participants diagnosed with leptomeningeal metastasis disease (LMM), a condition where cancer has spread to the fluid and membranes surround the brain and spinal cord. The purpose of this study is to find out whether a consumer Smartwatch can continuous…
Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Virtual nature walks could lift mood for elderly patients stuck in hospital
Symptom relief Not yet recruitingProlonged hospitalization can reduce opportunities for independent activity, choice, and control and may contribute to passivity, low mood, anxiety, and distress in some older adults. Zenctuary VR+ is a seated, nature-based virtual reality program that combines calming environmen…
Sponsor: Moholy-Nagy University of Art and Design • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
CAR-T breakthroughs come with infection risks – new study aims to decode them
Knowledge-focused Not yet recruitingThis study includes adults with multiple myeloma or B-cell lymphoma who were/will be treated with CAR-T cell therapy at the IRCCS Azienda Ospedaliero-Universitaria di Bologna. The aim is to better understand infections that may occur during the first year after CAR-T treatment, i…
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
Can a common blood thinner outsmart a hidden heart risk?
Disease control Not yet recruitingThe Lp(a)-PLAT Study is designed to close a critical evidence gap in cardiovascular prevention for the roughly 20% of the population who carry genetically determined elevations in lipoprotein(a) - a recognised pro-thrombotic and pro-atherosclerotic risk factor. Its objective is t…
Sponsor: François MACH • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can a Partner-Powered program tame high blood pressure?
Disease control Not yet recruitingThe researchers will invite 30 patients in primary care who have high blood pressure to participate in this health program with a supportive partner of their choosing (these will be the "participant pairs"). Participant pairs will be invited to complete the Heart Care Pairs healt…
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Meditation may ease stress and improve life for glaucoma patients
Symptom relief Not yet recruitingGlaucoma is a chronic disease that causes loss of vision and potentially blindness as a result of optic nerve damage, often due to increased intraocular pressure. Glaucoma is currently the leading cause of irreversible blindness worldwide.1 In 2020, 4.1 million and 3.6 million ad…
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Which nerve block wins the battle against Post-Surgery pain?
Symptom relief Not yet recruitingBecause laparoscopic procedures have a number of benefits over open procedures, they have completely changed the surgical industry.(1) Laparoscopic cholecystectomy (LC) is a minimally invasive technique that usually yields less discomfort following surgery, shorter hospital stays…
Sponsor: Kasr El Aini Hospital • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
What keeps healthcare workers logging in? a trial tests two strategies
Symptom relief Not yet recruitingThe goal of this clinical trial is to test which engagement strategies lead to more participation in a digital mental health program among healthcare workers. The main questions it aims to answer is: * Does content tailoring increase engagement with the digital program? * Does h…
Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Can a weekly shot bring antibody levels to safety in untreated immune deficiency?
Disease control Not yet recruitingPrimary immunodeficiency disease (or PIDD) is a group of conditions in which the immune system does not work properly. Some people with PIDD do not make enough antibodies. Antibodies are proteins that help to either protect the body from infections or fight infections. The main t…
Phase 4 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC